Evaluating the Effectiveness of Prolonged Exposure Therapy for Post-Traumatic Stress Disorder (PTSD) in Reducing Symptoms and Improving Quality of Life among Veterans of the Iran–Iraq War

"The effectiveness of Prolonged Exposure Therapy for Post-Traumatic Stress Disorder (PTSD) in reducing symptoms and improving the quality of life of veterans and combatants of the Eight-Year Iran-Iraq War."

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250806066778N1

Enrollment

Registered

2025-09-16

Start date

2025-09-22

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder – PTSD.

Interventions

In this study, the World Health Organization's 26-item short form of the Quality of Life Questionnaire (WHO-QOL-BREF) was used. The 17-item version of the Posttraumatic Stress Disorder Scale (intervie

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Active-duty or retired military personnel with a history of war-related trauma. Having war-related Post-Traumatic Stress Disorder (PTSD) with a medical record and currently under pharmacological treatment. No history of receiving psychological treatments prior to entering the study. Ability to read and write. Patient’s consent to participate in the study and signing the written informed consent form.

Exclusion criteria

Exclusion criteria: Suffering from other major psychiatric disorders (excluding PTSD and comorbid symptoms of depression and anxiety), such as personality disorders, psychotic disorders, or substance and alcohol addiction. Having suicidal thoughts. Possessing non-therapeutic motivations (e.g., seeking secondary gains such as increasing disability benefits). Presence of severe medical conditions or physical injuries, such as spinal cord lesions, that would cause significant difficulties for the patient’s attendance in therapy sessions.

Design outcomes

Primary

Measure	Time frame
Percentage improvement (Scruggs and Mastropiri, 1998) in single-subject research designs is one of the quantitative indicators for measuring the effectiveness of interventions, which shows the amount of change in behavior or the dependent variable as a percentage compared to the baseline situation. Timepoint: Effect size in single-subject research designs is a quantitative indicator used to measure the extent to which an intervention has an effect on the dependent treatment (the behavior or outcome under study) and is strength or change. Method of measurement: In the present study, the 17-item version of the Posttraumatic Stress Symptoms Scale (interview form) developed by Foa, Riggs, Danko, and Rothiam (1993) will be used.	—

Measure

Time frame

Percentage improvement (Scruggs and Mastropiri, 1998) in single-subject research designs is one of the quantitative indicators for measuring the effectiveness of interventions, which shows the amount of change in behavior or the dependent variable as a percentage compared to the baseline situation. Timepoint: Effect size in single-subject research designs is a quantitative indicator used to measure the extent to which an intervention has an effect on the dependent treatment (the behavior or outcome under study) and is strength or change. Method of measurement: In the present study, the 17-item version of the Posttraumatic Stress Symptoms Scale (interview form) developed by Foa, Riggs, Danko, and Rothiam (1993) will be used.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Amiri

Ardabil University of Medical Sciences

amiri100370@gmail.com+98 45 3353 4722

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026